Stock Alert! NACEL Energy Secures Competitive Advantage With Acquisition of Texas Wind Data

Stocks to Watch: NACEL Energy Corporation  (OTC BB:NCEN) , eFoodSafety.com (OTC BB:EFSF) , Jones Soda Co. (Nasdaq:JSDA), Protandim (OTC BB:LFVN), Symbollon Pharmaceuticals, Inc.  (OTC BB:SYMBA)

Featured Stock: NACEL Energy Corporation

(OTC BB:NCEN)

Current Price (1.86)

http://www.smallcapstockanalyst.com/

NACEL Energy Secures Competitive Advantage With Acquisition of Texas Wind Data

CASPER, WY--Mar 10, 2008 -- NACEL Energy Corporation (OTC BB:NCEN.OB - News) (Frankfurt:4FC.F - News) ("NACEL Energy"), an emerging developer and aggregator of wind power infrastructure generating clean, renewable energy for America, today announced it has acquired high quality wind data covering important wind energy development corridors in Texas. The collection of wind data over a period of years is essential to the development of any wind energy project. Wind data is captured by the placement of sophisticated meteorological towers extending up to 196 feet high which measure wind speed, direction, temperature, and barometric pressure. Continuous wind data over a three year period is considered of the highest quality by meteorological experts. NACEL Energy's acquisition encompasses wind data collected over a period of six years from fourteen meteorological towers located in West Texas.

NACEL Energy President Brian Lavery stated:

"NACEL Energy's ability to obtain wind data of the highest quality and ahead of our industry peers is a competitive advantage which ensures that our Company maintains a development pipeline of new wind energy projects to enhance our present operations and achieve our goal of developing 80 MW of generating capacity -- enough energy to serve 25,000 homes -- over a 36 month period. I want to thank the NACEL Energy Operations Team for a job well done."

About NACEL Energy Corporation

NACEL Energy is an emerging developer and aggregator of wind power infrastructure generating clean, renewable energy for America. The Company is one of the first in the nation developing COMMUNITY WIND -- utility-scale wind energy with a sustainable footprint and local partners. Founded in 2006 and headquartered in Casper Wyoming, NACEL Energy is a public company trading under the ticker symbol "NCEN."

For more information visit our website http://www.nacelenergy.com/.

NACEL Energy

The WIND POWER COMPANY(TM)

Notice regarding Forward-Looking Statements

Statements in this press release relating to Nacel Energy's plans, strategies, economic performance and trends, projections of results of specific activities or investments, and other statements that are not descriptions of historical facts may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking information is subject to risks and uncertainties, and actual results could differ materially from those currently anticipated due to a number of factors, which include, but are not limited to, risk factors inherent in Nacel Energy's business. Forward-looking statements may be identified by terms such as "may," "will," "should," "could," "expects," "plans," "intends," "anticipates," "believes," "estimates," "predicts," "forecasts," "potential," or "continue," or similar terms or the negative of these terms. Matters discussed in today's news release, including, without limitation; the belief that the business assumptions underlying the statement the Company will "achieve our goal of 80 MW of wind power generating capacity over 36 month period" are reasonable, and all other such similar statements of belief, are forward-looking statements that involve a number of risks and uncertainties. The actual future results of Nacel Energy could differ from these statements. Factors that could cause or contribute to such differences include, but are not limited to, the ability of Nacel Energy to acquire the capital necessary to fund its wind energy development plans; the ability of Nacel Energy's management to successfully execute partnership agreements with local wind energy developers; the ability of Nacel Energy to generate its projected internal rate of return from the wind energy projects it develops; and other additional factors discussed in "Risk Factors" and other sections of Nacel Energy's Securities and Exchange Commission filings available at http://www.sec.gov/. Although Nacel Energy believes that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements and Nacel Energy accepts no obligation to update these forward-looking statements.

Contact:

     Contact:

     NACEL Energy Investor Services

     1-888-242-5848

Source: NACEL Energy Corporation

For an in-depth analyst report, please visit:  http://www.smallcapstockanalyst.com/

eFoodSafety.com

(OTC BB:EFSF)

Current Price (0.21)

http://www.smallcapstockanalyst.com/

SCOTTSDALE, Ariz.--March 10--eFoodSafety.com, Inc. (OTCBB: EFSF, www.efoodsafety.com), a researcher and developer of nutraceutical and whole food products, is running commercials for its product CinnergenTM on several cable channels, including A & E, the Biography Channel, and The Weather Channel. These commercials are intended to help increase consumer awareness and support retail sales nationwide.         eFoodSafety.com, Inc., through its subsidiaries, offers technologies that enhance food and health conditions. It develops various products, including anthrax sporicidal, a germicidal cleaner, a wound care antiseptic, an herbicide, and an insect repellent. The company also distributes various products to physicians who then prescribe the products for their patients. It primarily distributes Talsyn-CI/bid scar cream that facilitates and improves the appearance, redness, and strength of scars; Cinnergen, a non prescription liquid whole food nutritional supplement that promotes glucose metabolism; and Trimmendous, a weight loss formula focusing on the body's 24-hour metabolic processes. eFoodSafety.com markets its products in the United States and internationally through various nonexclusive distribution agreements, as well as trade shows, and industry-related events and seminars. The company was incorporated in 1998 and is based in Scottsdale, Arizona.

Jones Soda Co.

(Nasdaq:JSDA)

Current Price (4.34)

http://www.smallcapstockanalyst.com/

SEATTLE--March 10--Jones Soda Co. (the “Company” or “Jones”) today announced results for fiscal year ended December 31, 2007 and the fourth quarter of 2007.Gross sales increased 14.7% from $39.5 million to $45 million for the year ended December 31, 2007 over the prior year. For the same period, case equivalent sales increased 21.8% from 4.8 million to 5.8 million.               Headquartered in Seattle, Washington, Jones Soda Co., manufactures its Jones Soda, Jones Naturals, Jones Energy and Whoopass brands and sells it through its distribution network in select markets across North America. A leader in the premium soda category, Jones is known for its innovative labeling technique that incorporates always-changing photos sent in from its consumers. Jones Soda is sold through traditional beverage retailers and everywhere you'd never expect to find a soda.

Protandim

(OTC BB:LFVN)

Current Price (0.30)

http://www.smallcapstockanalyst.com/

GREENWOOD VILLAGE, Colo.--March 10--LifeVantage Corporation (OTCBB: LFVN - News) announces that Jan Strode, prominent industry expert, advisor and strategist to companies ranging from start-ups to Fortune 100 companies on the topics of marketing, communications and sales, and Peter Baloff, nationally recognized creative consultant, have joined forces with LifeVantage, the maker of Protandim (www.protandim.com) to spearhead creative, marketing, and national public relations efforts. Protandim is the patented nutritional supplement that is clinically proven to slow the progressive rate of aging by increasing the body’s natural antioxidant protection at the cellular level.                       Protandim® is a unique approach to fighting the effects of cell-damaging free radical molecules which advance the aging process, including many of the diseases of aging. The patented dietary supplement increases the body's natural antioxidant protection by inducing the cells of the body to produce naturally occurring protective antioxidant enzymes, a process which is thousands of times more effective than traditional vitamin-mineral supplements. Free radical damage occurs when a person is subjected to environmental stresses and generally increases with age. Data from a peer-reviewed scientific study in men and women, sponsored by LifeVantage, shows that after 30 days of taking Protandim®, the level of circulating toxins produced by free radicals decreased an average of 40 percent, slowing the progressive aging factors to the level of a 20 year old. With continued use, the decrease was maintained at 120 days.

Symbollon Pharmaceuticals, Inc.

(OTC BB:SYMBA)

Current Price (0.85)

http://www.smallcapstockanalyst.com/

FRAMINGHAM, MA--Mar 10, 2008 -- Symbollon Pharmaceuticals, Inc. (OTC BB:SYMBA.OB - News) today announced that it has signed a term sheet with all shareholders of Xi'an Maidefa Pharmaceutical Co., Ltd. ("Medpharm") to acquire Medpharm. Medpharm is a fully integrated pharmaceutical company currently marketing 23 products to the dairy and aquaculture markets in China. Medpharm was founded by Dr. Yongjun Duan, the former director of research and development of Symbollon.                  Symbollon Pharmaceuticals, Inc. (OTC BB:SYMBA.OB - News) is a specialty pharmaceutical company focused on the development and commercialization of proprietary drugs based on its molecular iodine technology. Symbollon is conducting a Phase III clinical trial evaluating IoGen as a potential treatment for moderate to severe periodic pain and tenderness (clinical mastalgia) associated with fibrocystic breast disease (FBD). FBD is a condition that affects approximately 20 to 33 million women in the U.S., and there are approximately 7 to 13 million women suffering from clinical periodic mastalgia. The Company believes IoGen also may be useful in treating and/or preventing endometriosis, ovarian cysts, and premenopausal breast cancer. Symbollon is also in preclinical development of antimicrobial products based on the same molecular iodine technology, and intends to investigate the potential effectiveness of its technology in applications such as dermatology, oral care, upper respiratory tract conditions, urinary tract infection and wound care. For more information about Symbollon, please visit the company's website at http://www.symbollon.com.

Penny Stock research reports are provided by SmallCapStockAnalyst.com, where visitors can sign up for our penny stock and Small Cap Stock newsletter. The newsletter will update investors with Growth Stocks when we begin coverage on new small cap companies. Penny Stocks trade in the Small Cap Stock Market, being informed is a critical component to making decisions. Penny Stock coverage from SmallCapStockAnalyst.com strives to keep you, the Investor, updated on companies looking to move ahead of the pack. Sign up today to receive growth stock tips and smallcap newsletter to stay informed of your investments. Allow SmallCapStockAnalyst.com to provide you with the latest research reports on pennystocks and Growth Stock Picks for your Stock Investing needs. SmallCapStockAnalyst.com specializes in providing investor relations and disseminating information to the small cap stock investor.

Smallcapstockanalyst.com is owned and operated by Iron Consulting LLC

Verify all claims and do your own due diligence. Iron Consulting profiles are not a solicitation or recommendation to buy, sell or hold securities. Iron Consulting is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. Iron Consulting is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17(b), Smallcapstockanalyst.com is owned and operated by Iron Consulting. Iron Consulting www.ironconsultinginc.com has receive thirty six thousand dollars from Equity Alliance Intl. for one month of internet marketing services, from Equity Alliance Int. LLC www.equityallianceir.com for its marketing and consulting services. Neither Iron Consulting nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this e-mail, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since Iron Consulting receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in Iron Consulting statements and opinions and such statements and opinions cannot be considered independent. Iron Consulting and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Iron Consulting services are often paid for using free-trading shares. Iron Consulting may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.